Simply Wall St.
How Good Is Teva Pharmaceutical Industries Limited (NYSE:TEVA), When It Comes To ROE?
➖
AI Sentiment
Neutral
5/10
Teva Pharmaceutical Industries Limited News
Latest updates and market news for TEVA
9 news
Feb 3 - Feb 9, 2026
Page 1
Insider Monkey
Is Teva Pharmaceutical Industries Limited (TEVA) an Undervalued Stock Relative to Its Long-Term Potential?
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
How The Shifting 2026 Pipeline Story Is Reshaping Teva Pharmaceutical Industries’ Valuation
📊
AI Sentiment
Positive
7/10
Insider Monkey
Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat
📈
AI Sentiment
Highly Positive
9/10
![Teva Canada Announces Approval of Expanded Indication of [Pr]AJOVY® (fremanezumab solution for subcutaneous injection), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/5b5baf25-ed7b-4296-9fd3-0d2f4067cb78.jpg)
Simply Wall St.
Evaluating Teva Pharmaceutical Industries (TEVA) After Earnings Beat And Return To Profitability
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Deckers Outdoor Corporation (DECK): A Bull Case Theory
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
📈
AI Sentiment
Highly Positive
8/10
Share this news page